Shire sales rocket with 25% growth
July 29, 2011Sales and Marketing ADHD, Fabry disease, Gaucher's disease, Shire
Specialist pharma company Shire has posted exceptionally strong results for the second quarter, increasing its product sales by 30% and …
Witty backs Britain as manufacturing, R&D location
July 29, 2011Manufacturing and Production, Research and Development GSK
GlaxoSmithKline chief executive Andrew Witty has promised to expand operations in the UK in both manufacturing and R&D, saying that …
Red Door appoints Julia Holt
July 29, 2011Medical Communications appointment, medical communcations
Julia Holt has joined Red Door Communications from Apothecom Huntsworth Health as an associate director and member of the management …
Ex-LeapFrog employees launch med comms agency
July 29, 2011Medical Communications medical communications news
A quartet of former employees at LeapFrog have banded together to launch a new UK med comms agency. Bamboo Medical …
Sanofi battles strong headwinds in second quarter
July 29, 2011Sales and Marketing Sanofi
Sanofi’s acquisition of Genzyme helped its revenue grow in the second quarter, but underlying growth from the French firm disappointed. …
Prescription sales soar in England
July 29, 2011Sales and Marketing NHS, prescribing
New data shows that prescription sales increased by more than two-thirds in England over the last decade, but a majority …
Sanofi appoints head of strategy
July 28, 2011Sales and Marketing appointment, sales and marketing
Dr David-Alexandre Gros has joined Sanofi as chief strategy officer with a remit that covers all the group’s business development …
Lilly releases details of US doctor payments
July 28, 2011Medical Communications, Sales and Marketing industry reputation, lilly
Lilly has released details of its payments to doctors and healthcare organisations in the US. The company paid $48.1 million …
A chronic problem for the health service
July 27, 2011Sales and Marketing NHS, long term conditions
Sir John Oldham is not widely known outside the Department of Health, but he might just have the most difficult …
GSK sales down on Avandia and pandemic products
July 27, 2011Research and Development, Sales and Marketing GSK
GlaxoSmithKline has posted a slide in revenue for the second quarter, but is buoyed by strong underlying growth. Sales were …
NICE recommends thalidomide ahead of Velcade
July 27, 2011Sales and Marketing NICE, Thalidomide, Velcade
NICE has recommended Celgene’s thalidomide ahead of J&J’s Velcade for multiple myeloma. Celgene’s drug is recommended in combination with an …
Contract research news in brief
July 27, 2011Research and Development research and development news
PPD plays down sell-off rumours, Icon sees a steep profit decline, plus updates from Beaufort, PharmaNet, ClinStar and Biofocus/IMD. PPD …
Open Health appoints three new partners
July 26, 2011Medical Communications apppointment, medical communications
New UK comms agency Open Health has strengthened its management team, appointing three new partners. Andy Bell, Cory Inglis and …
Augmentin recall expanded on contamination fears
July 26, 2011Manufacturing and Production, Sales and Marketing Augmentin, GSK, recalls
GlaxoSmithKline has been drawn further into concerns about contamination of pharmaceuticals, foods and beverages with plasticiser compounds, after authorities in …
NICE consults on asthma drug reducing procedure
July 26, 2011Sales and Marketing NICE, asthma
NICE has launched a consultation in the UK on a new medical procedure which, if it proves safe and effective, …
Janssen’s prostate cancer drug gains European backing
July 26, 2011Sales and Marketing Zytiga, prostate cancer
Janssen’s prostate cancer treatment Zytiga has been recommended by Europe’s CHMP, paving the way for possible third quarter launch. The …
Boost for Ireland’s pharma sector as new facility announced
July 26, 2011Manufacturing and Production Sangart, pharma manfacturing news, pharma manufacturing news
Around 120 jobs will be created in Cork, Ireland, thanks to a decision by pharmaceutical company Sangart to build a …
Baxter fined for workplace safety violations
July 26, 2011Manufacturing and Production Baxter International, pharma manufacturing news
Baxter Healthcare has been fined $371,000 by the California state authorities for “deliberate and wilful” workplace safety violations at a …
The format for the submission of information on medicines is published
July 25, 2011The European Medicines Agency has recently published the format in which pharmaceutical companies will need to submit information regarding authorised …
FDA sets aside $700,000 for manufacturing research
July 25, 2011Manufacturing and Production FDA, pharma manufacturing news
The FDA has set aside $700,000 to help fund research that “improves reliability of pharmaceutical product manufacturing and quality across …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
